Skip to main content
SpringerLink
Log in

The Chinese non-small-cell lung cancer (NSCLC) drug market is expected to more than double by 2013

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources.Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013. Media Release: 6 May 2009. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Chinese non-small-cell lung cancer (NSCLC) drug market is expected to more than double by 2013. Pharmacoecon. Outcomes News 579, 15 (2009). https://doi.org/10.2165/00151234-200905790-00040

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905790-00040

Keywords

Search

Navigation